Business Context and Reporting Period
This Form 6-K filing by Coca-Cola Europacific Partners Plc covers the period from October 1 to October 31, 2022, with the report filed on November 1, 2022. The document serves as a compliance report under the FCA's Disclosure Guidance and Transparency Rules, detailing transactions by Persons Discharging Managerial Responsibilities (PDMRs) and providing an update on the company's total voting rights and share capital.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is strictly limited to regulatory disclosures regarding share transactions and capital structure.
- Share Capital: 456,907,147 ordinary shares of €0.01 each in issue as of October 31, 2022.
- Voting Rights: 456,907,147 total voting rights (one vote per share).
- Treasury Shares: None.
Material Changes
The filing reports specific share acquisitions by PDMRs and persons closely associated with them (PCAs) during October 2022. These transactions were executed via the Nasdaq Stock Market LLC.
- October 12, 2022: Three executives (Ana Callol, Jose Antonio Echeverria, Victor Rufart) acquired shares under the Employee Share Purchase Plan at a weighted average price of approximately USD $45.47.
- October 19, 2022: Six executives (Manik Jhangiani, Clare Wardle, Peter Brickley, Stephen Lusk, Leendert den Hollander, Stephen Moorhouse) acquired shares. Most transactions were under the UK Share Plan, resulting in a weighted average price of approximately USD $22.55 (reflecting a mix of paid and non-paid components). One transaction by Stephen Lusk was under the UK Shareshop at approximately USD $45.77.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is a statutory notification of share ownership changes and capital totals.
Investor Verification Checklist
- Verify the total number of outstanding shares (456,907,147) against the company's latest quarterly or annual report to confirm capital structure consistency.
- Review the specific share plans (Employee Share Purchase Plan, UK Share Plan, UK Shareshop) referenced in the PDMR transactions to understand the dilution impact and pricing mechanisms.
- Confirm that the reported share prices (ranging from ~$22.55 to ~$45.77) align with the market price of the company's ordinary shares on the Nasdaq during the transaction dates.
- Note that this filing contains no operational or financial performance data; investors should refer to Form 20-F or quarterly earnings releases for financial metrics.